Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats
Open Access
- 1 June 2004
- journal article
- Published by Wiley in Cancer Science
- Vol. 95 (6) , 481-486
- https://doi.org/10.1111/j.1349-7006.2004.tb03236.x
Abstract
Pomegranate (Punica granatum L.) seed oil (PGO) contains more than 70% cis(c)9,frans(f)11,c13–18:3 as conjugated linolenic acids (CLN). Our previous short‐term experiment demonstrated that seed oil from bitter melon (Momordica charantia) (BMO), which is rich in c9,t11,t13‐CLN, inhibited the occurrence of colonic aberrant crypt foci (ACF) induced by azoxymethane (AOM). In this study, we investigated the effect of dietary PGO on the development of AOM‐induced colonic malignancies and compared it with that of conjugated linoleic acid (CLA). To induce colonic tumors, 6‐week old male F344 rats were given subcutaneous injections of AOM (20 mg/kg body weight) once a week for 2 weeks. One week before the AOM treatment they were started on diet containing 0.01%, 0.1%, or 1%±PGO or 1% CLA for 32 weeks. Upon termination of the bioassay (32 weeks) colon tumors were evaluated histopathologically. AOM exposure produced colonic adenocarcinoma with an incidence of 81% and multiplicity of 1.88±1.54 at week 32. Administration of PGO in the diet significantly inhibited the incidence (AOM+0.01% PGO, 44%, P<0.05; AOM+0.1% PGO, 38%, P<0.01; AOM+1% PGO, 56%) and the multiplicity (AOM+0.01% PGO, 0.56±0.73, P<0<01; AOM+0.1% PGO, 0.50±0.73, P<0.005; AOM+1% PGO, 0.88±0.96, P<0.05) of colonic adenocarcinomas, although a clear dose‐response relationship was not observed at these dose levels. CLA feeding also slightly, but not significantly, reduced the incidence and multiplicity of colonic adenocarcinomas. The inhibition of colonic tumors by PGO was associated with an increased content of CLA (c9,t11–18:2) in the lipid fraction of colonic mucosa and liver. Also, administration of PGO in the diet elevated expression of peroxisome proliferator activated receptor (PPAR) γ protein in the nontumor mucosa. These results suggest that PGO rich in c9,t11,c13‐CLN can suppress AOM‐induced colon carcinogenesis, and the inhibition is associated in part with the increased content of CLA in the colon and liver and/or increased expression of PPARγ protein in the colon mucosa.This publication has 47 references indexed in Scilit:
- Therapeutic potential of thiazolidinediones as anticancer agentsExpert Opinion on Investigational Drugs, 2003
- Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in miceGastroenterology, 2003
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Activation of PPARgamma may mediate a portion of the anticancer activity of conjugated linoleic acidMedical Hypotheses, 2000
- Conjugated linoleic acid activates peroxisome proliferator-activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague–Dawley ratsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Effects of dietary conjugated linoleic acid on DNA adduct formation of PhIP and IQ after bolus administration to female F344 ratsNutrition and Cancer, 1998
- Effect of diet on human carcinogenesisCritical Reviews in Oncology/Hematology, 1997
- Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesisNutrition and Cancer, 1997
- Dietary conjugated Linoleic acid modulation of phorbol ester skin tumor promotionNutrition and Cancer, 1996
- Occurrence of unusual fatty acids in plantsProgress in the Chemistry of Fats and other Lipids, 1971